Search

Ipsen SA.

Închisă

SectorFinanțe

148.5 -0.27

Rezumat

Modificarea prețului

24h

Curent

Minim

146.69

Maxim

149.9

Indicatori cheie

By Trading Economics

Venit

294M

403M

Vânzări

334M

2.2B

P/E

Medie Sector

23.317

19.443

Randament dividend

1.12

Marjă de profit

18.405

Angajați

5,535

EBITDA

556M

1B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+14.09% upside

Dividende

By Acuity

Randament dividend

Medie Sector

1.12%

4.82%

Statistici piață

By TradingEconomics

Capitalizare de piață

-1.2B

12B

Deschiderea anterioară

148.77

Închiderea anterioară

148.5

Ipsen SA. Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

18 oct. 2026, 23:32 UTC

News

Arthur Hayes stated on social media that quantum computing should not deter Bitcoin investment and cautioned against the security risks of reusing wallet addresses.

18 oct. 2026, 23:32 UTC

Macro News
News

Bitcoin is trading modestly higher, with Arthur Hayes noting that quantum computing concerns shouldn't deter investors from holding the asset.

18 oct. 2026, 20:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid a broader selloff in technology stocks due to concerns over AI financing and inflation data.

18 oct. 2026, 20:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid a broader selloff in technology stocks due to concerns over AI financing and inflation data.

17 oct. 2026, 22:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid broader market weakness in technology stocks and concerns over AI financing issues.

17 oct. 2026, 22:01 UTC

News

Ethereum is trading lower, continuing a downward trend amid broader market weakness in technology stocks due to concerns over AI financing issues.

17 oct. 2026, 00:02 UTC

News

Tesla Inc shares are lower in after-market hours as analyst Gary Black cautions against overhyping a potential merger with SpaceX.

17 oct. 2026, 00:02 UTC

Social Media
News

Morgan Stanley lowers Netflix's price target to $80 from $83, citing stagnant viewing hours and concerns about engagement trends ahead of next week's earnings report.

17 oct. 2026, 00:02 UTC

News

Fastenal Co's stock advanced in after-market trading, supported by a 15.5% sales increase highlighted during its recent earnings call.

17 oct. 2026, 00:02 UTC

Social Media
News

Bank of America shares were roughly flat in after-market trading, following a 7-8% decline post-earnings amid analyst concerns over regulatory costs and profitability targets.

17 oct. 2026, 00:01 UTC

News

RTX Corp's Raytheon unit secured a $729 million contract for the UAS Integrated Defeat System, contributing to higher shares in after-market hours.

17 oct. 2026, 00:01 UTC

News

Shah Capital has withdrawn its investment adviser registration and reduced its stake in Novavax, selling 2.87 million shares at $11.35 each.

17 oct. 2026, 00:01 UTC

News

Lyft shares declined in after-market trading as the company announced the launch of Alcove, a new chauffeur brand targeting premium corporate transportation.

17 oct. 2026, 00:01 UTC

News

General Electric Co shares are slightly lower in after-market trading amid broader market fluctuations, despite securing a deal for over 300 LEAP-1B engines with CFM International.

17 oct. 2026, 00:01 UTC

Correlated Moves
News

Coinbase Global Inc shares are trading modestly lower in after-market hours, reflecting a decline in the broader cryptocurrency market and Bitcoin's slight drop.

17 oct. 2026, 00:01 UTC

News

Boeing secures up to $80 million contract from the U.S. Navy for MQ-25A Stingray support, while sales chief McMullen announces retirement.

16 oct. 2026, 23:52 UTC

News

Dell Technologies Inc shares are moving lower in after-market hours amid inflation concerns affecting tech valuations, despite being named a core AI partner for Honeywell.

16 oct. 2026, 23:51 UTC

News

Baker Hughes Co. has a market capitalization of approximately $54.96 billion, experiencing a modest increase in after-market trading following Friday's close.

16 oct. 2026, 23:46 UTC

News

Scholar Rock grants inducement equity awards for 61.02k shares to new employees as part of its strategy to attract talent for ISEMBLYD commercialization.

16 oct. 2026, 23:46 UTC

News

Apollo Commercial Real Estate Finance Inc. plans to voluntarily delist from the NYSE, with the last trading day expected on November 6, 2026.

16 oct. 2026, 23:41 UTC

News

General Electric Co shares are moving lower in after-market trading following a deal with CFM International for over 300 LEAP-1B engines for Turkish Airlines.

16 oct. 2026, 23:41 UTC

News

Boeing Co. secures an $80 million contract from the U.S. Navy for the MQ-25A Stingray unmanned aircraft system, expected to be completed by October 2031.

16 oct. 2026, 23:41 UTC

News

Tesla Inc shares are trading modestly lower in after-market hours, continuing a trend of decline and remaining significantly below their 20-day moving average.

16 oct. 2026, 23:36 UTC

News

Hingham Institution for Savings reports third-quarter net income of $12.67 million, a decline from $17.30 million year-over-year, with overall performance metrics indicating a decrease.

16 oct. 2026, 23:31 UTC

News

Celanese announces global price increases for LCP products, citing strong demand and rising costs, as shares decline in after-market trading.

16 oct. 2026, 23:31 UTC

Correlated Moves
News

Coinbase Global Inc shares are trading modestly lower in after-market hours, influenced by a decline in Bitcoin prices and broader market trends.

16 oct. 2026, 23:16 UTC

News

In after-market trading, Steel Dynamics Inc is rising, with analysts expecting earnings of approximately $5.40 per share on revenue of around $6.57 billion.

16 oct. 2026, 23:12 UTC

Social Media
News

Morgan Stanley lowers Netflix's price target to $80 from $83, citing stagnant viewing hours and concerns over engagement trends ahead of earnings report.

16 oct. 2026, 23:11 UTC

News

Lyft Inc shares declined in after-market trading following the announcement of its new premium chauffeur brand, Alcove, amid broader market weakness.

16 oct. 2026, 23:11 UTC

News

RTX Corp's Raytheon business secured a $729 million contract for the Ku-band Radio Frequency Sensor and Coyote interceptor, boosting shares higher in after-market hours.

Comparație

Modificare preț

Ipsen SA. Așteptări

Obiectiv de preț

By TipRanks

14.09% sus

Prognoză pe 12 luni

Medie 170 EUR  14.09%

Maxim 235 EUR

Minim 130 EUR

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruIpsen SA. - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

4 ratings

1

Cumpărare

1

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Ipsen SA.

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.
help-icon Live chat